Medical Devices

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

By uniting 250 years of heritage, Bradford Labs is not just rebranding. It's building a one-stop-shop to solve the biggest headaches for modern brands.

Nephrodite's implantable dialysis system just entered a key FDA program, signaling a major shift in treating kidney failure. Is freedom from the dialysis chair finally in sight?

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.

With a new line of 'plug-and-play' 3A certified separators, Tessa tackles a risky market gap, offering producers a simple path to PMO compliance.

A new study on couples' supplements shows impressive well-being gains, but a closer look at the methodology reveals a gap between marketing and hard science.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

A California small business beat 11 rivals for a landmark FBI armor contract. The Nguyen Report dissects the strategy and tech setting a new industry standard.

Shanti Recovery & Wellness gains DHCS accreditation, launching a virtual IOP that combines clinical therapy with holistic practices for California adults.

Pluri is moving its advanced cell-expansion tech from the lab to the lucrative U.S. aesthetics market. Is this a savvy commercial pivot or a risky gamble?

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

A new manufacturing deal sees Bluejay Diagnostics bet on U.S. resilience. It's a strategic retreat from global risk for a firm facing a long regulatory road.

A pivotal trial completes enrollment at a record pace while the AMA lays the groundwork for billing. ShiraTronics is rewriting the medtech playbook.

A Japanese firm has achieved a breakthrough in manufacturing ultra-smooth capillary tubes, a tiny component set to unlock major advances in medicine and tech.

With a seasoned drug developer at the helm, preclinical biotech FundaMental Pharma signals a major push to bring its novel TRD therapy through the clinical gauntlet.

China's oldest watchmaker is democratizing high horology on Kickstarter. We break down the tech, the value, and the strategy behind this bold global play.

A pioneer in professional chemical peels, PCA SKIN is strategically expanding its legacy into the booming at-home market. Their new Triple Exfoliation Peel Pads exemplify operational innovation, offering clinic-grade results and barrier support for the discerning consumer.